Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Tyacke

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Synapse (New York, N.Y.)|June 20, 2015
Optimising PET approaches to measuring 5-HT release in human brainRobin J Tyacke, David J Nutt
International Journal of Molecular Sciences|June 28, 2023
Imidazoline-I2 PET Tracers in NeuroimagingChristine A Parker, David J Nutt, Robin J Tyacke
Advances in Pharmacology (San Diego, Calif.)|July 27, 2010
GABAB receptors in addiction and its treatmentRobin J Tyacke, Anne Lingford-Hughes, Laurence J Reed, et al.
European Journal of Pharmacology|August 15, 2002
Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brainEmma S J Robinson, Robin J Tyacke, David J Nutt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 29, 2010
Measuring endogenous 5-HT release by emission tomography: promises and pitfallsLouise M Paterson, Robin J Tyacke, David J Nutt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 10, 2014
Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalizationDarren R Quelch, Loukia Katsouri, David J Nutt, et al.
Acta Poloniae Pharmaceutica|April 6, 2006
Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-olsAnita Kornicka, Franciszek Saczewski, Robin J Tyacke, et al.
Bjpsych Open|September 22, 2021
Impact of COVID-19 restrictions on alcohol consumption behavioursEmily O C Palmer, William Trender, Robin J Tyacke, et al.
Neuropharmacology|October 19, 2006
In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sitesLouise M Paterson, Robin J Tyacke, Emma S J Robinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigationRichard A Glennon, Brian Grella, Robin J Tyacke, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Synapse (New York, N.Y.)|June 20, 2015
Optimising PET approaches to measuring 5-HT release in human brainRobin J Tyacke, David J Nutt
International Journal of Molecular Sciences|June 28, 2023
Imidazoline-I2 PET Tracers in NeuroimagingChristine A Parker, David J Nutt, Robin J Tyacke
Advances in Pharmacology (San Diego, Calif.)|July 27, 2010
GABAB receptors in addiction and its treatmentRobin J Tyacke, Anne Lingford-Hughes, Laurence J Reed, et al.
European Journal of Pharmacology|August 15, 2002
Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brainEmma S J Robinson, Robin J Tyacke, David J Nutt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 29, 2010
Measuring endogenous 5-HT release by emission tomography: promises and pitfallsLouise M Paterson, Robin J Tyacke, David J Nutt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 10, 2014
Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalizationDarren R Quelch, Loukia Katsouri, David J Nutt, et al.
Acta Poloniae Pharmaceutica|April 6, 2006
Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-olsAnita Kornicka, Franciszek Saczewski, Robin J Tyacke, et al.
Bjpsych Open|September 22, 2021
Impact of COVID-19 restrictions on alcohol consumption behavioursEmily O C Palmer, William Trender, Robin J Tyacke, et al.
Neuropharmacology|October 19, 2006
In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sitesLouise M Paterson, Robin J Tyacke, Emma S J Robinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigationRichard A Glennon, Brian Grella, Robin J Tyacke, et al.
Pageof 4